COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Common Stock Purchase Warrant • April 11th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the loan of up to $5,000,000 made upon the entry into of the Equity and Business Loan Agreement dated as of the date hereof among NKGEN OPERATING BIOTECH, INC., NKGEN BIOTECH, INC. (the “Company”), and BDW INVESTMENTS LLC (including any permitted and registered assigns, the “Holder”), (the “Agreement”)), the Holder is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from the Company), 1,000,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 11th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • New York
This Registration Rights Agreement (this “Agreement”) is made as of April 5, 2024 by and among (i) NKGen Biotech, Inc., a Delaware corporation (formerly known as Graf Acquisition Corp. IV, the “Company”) and (ii) BDW Investments LLC, a Delaware limited liability company (the “Holder”).
EQUITY AND BUSINESS LOAN AGREEMENTRegistration Rights Agreement • April 11th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • New York
